Sulfhydryl Drug‐induced Eruption: A Clinical and Histological Study

Sulfhydryl drug‐induced skin eruptions were studied clinically and histologically in 23 patients. In this study, tiopronin, D‐penicillamine, captopril and gold sodium thiomalate were considered to be sulfhydryl drugs, because they have a thiol group or release sulfhydryl compounds. The clinical features included skin eruptions that were maculopapular, erythema mutiforme‐like, eczematous, psoriasis‐like, seborrheic dermatitis‐like, Gibert‐like, lichen planus‐like, and pemphigus‐like. These clinical findings were reminiscent of the wide variety of eruptions seen in cutaneous graft‐versus‐host reactions (GVHR). Histologically, areas of vacuolation and eosinophilic necrosis with a satellite infiltrate of lymphoid cells were seen in the epidermis, and perivascular infiltrates were noted in the dermis. These findings were similar to the histological picture of cutaneous GVHR. In skin tests with sulfhydryl compounds, 19 out of 20 subjects showed positive reactions, and autoantibodies were found in 8 out of 12 subjects tested.

[1]  D. Mutasim,et al.  Drug-induced pemphigus. , 1993, Dermatologic clinics.

[2]  U. Hurtenbach,et al.  Immunity to D-penicillamine: genetic, cellular, and chemical requirements for induction of popliteal lymph node enlargement in the mouse. , 1987, Journal of immunology.

[3]  B. Tank,et al.  Causative Agents and Pathogenicity in latrogenic Cutaneous Autoimmunity , 1987, International journal of dermatology.

[4]  M. Leibowitch,et al.  [Induced pemphigus]. , 1987, Annales de dermatologie et de venereologie.

[5]  K. Maclennan,et al.  Severe cutaneous reactions to captopril and enalapril; histological study and comparison with early mycosis fungoides. , 1986, Journal of clinical pathology.

[6]  I. Jaffe Adverse effects profile of sulfhydryl compounds in man. , 1986, The American journal of medicine.

[7]  Z. Ikezawa,et al.  Pemphigus Following in D-Penicillamine , 1986 .

[8]  S. Pals,et al.  Graft-versus-host reactions: clues to the etiopathology of a spectrum of immunological diseases. , 1984, Immunology today.

[9]  D. Perrett,et al.  Free thiomalate levels in patients with rheumatoid arthritis treated with disodium aurothiomalate: relationship to clinical outcome of therapy. , 1984, Annals of the rheumatic diseases.

[10]  H. Ohmori,et al.  Augmentation of in vitro antibody response by disulfide compounds. II. T cell-mediated augmentation by oxidized dithiothreitol, an intramolecular disulfide. , 1984, Immunopharmacology.

[11]  D. Perrett,et al.  Circulating thiomalate after administration of disodium aurothiomalate: impurity or active metabolite? , 1984, The Journal of rheumatology.

[12]  K. Bendtzen,et al.  Immunosuppressive actions of gold salts. , 1983, Scandinavian journal of rheumatology. Supplement.

[13]  V. Ruocco,et al.  Pemphigus provoked by D(-)penicillamine. An experimental approach using in vitro tissue cultures. , 1982, Dermatologica.

[14]  C. Cohen,et al.  Captopril‐Induced Skin Eruptions , 1982, Journal of clinical pharmacology.

[15]  H. Ohmori,et al.  Augmentation of in vitro antibody response by disulfide compounds , 1982 .

[16]  E. Jellum,et al.  Fate of the gold and the thiomalate part after intramuscular administration of aurothiomalate to mice. , 1980, Annals of the rheumatic diseases.

[17]  R. Storb,et al.  Histopathology of graft-vs.-host reaction (GvHR) in human recipients of marrow from HL-A-matched sibling donors. , 1974, Transplantation proceedings.

[18]  A. Ackerman,et al.  Gold dermatitis. A clinical and histopathological study. , 1974, Archives of dermatology.

[19]  J. Revuz,et al.  Pemphigus chez un malade traité par pénicillamine pour maladie de Wilson. , 1969 .